5d 1m 3m 1y 5y 10y
There are no Transcripts on RVXCF.
There are no News articles on RVXCF.
RVXCF vs. ETF Alternatives
Saturday, Mar 62010, 1:35 PMPfizer (PFE) sunk $2B+ into R&D for a new cholesterol drug, but was unsuccessful. Now meet Resverlogix (RVXCF.PK), the Canadian firm being courted by Big Pharma because it may succeed where Pfizer failed. Shares rose 38% yesterday, and have more than doubled this year. |Saturday, Mar 62010, 1:35 PM| Comment!